A Doody's Core Title 2012
Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.
With contributions from experts across the United States and Canada, Prostate Cancer details the current management of prostate cancer and reviews new therapies in development for prostate cancer, with an emphasis on castration-resistant prostate cancer (CRPC). Coverage includes discussion of multiple new agents that have been shown to impact overall survival or improve skeletal-related events in metastatic CRPC as well as articles covering new data on screening and prevention, integration of surgery and radiation with newly emerging medical therapies, and coverage of the newest developments in immunotherapy. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows.
Included in Prostate Cancer:
"synopsis" may belong to another edition of this title.
James L. Gulley, MD, PhD, FACP, Director, Clinical Immunotherapy Group, Senior Investigator, National Cancer Institute
Jame Abraham, MD, FACP, is Bonnie Wells Wilson Distinguised Professor and Eminent Scholar, Chief Section of Hematology - Oncology, and Medical Director, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia
"About this title" may belong to another edition of this title.
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-230357
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABBB-51071
Seller: BOOKWEST, Phoenix, AZ, U.S.A.
Hardcover. Condition: New. 1st Edition. SHRINK-WRAPPED: US SELLER SHIPS FROM USA. Seller Inventory # ORD3-S0-HC-1936287463-1P3-B10-BRN-2011
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Seller Inventory # SNTA-51071
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 200. Seller Inventory # 2614285273
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 200. Seller Inventory # 11421190
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 200. Seller Inventory # 1814285267
Quantity: 4 available
Seller: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, United Kingdom
Condition: As New. Seller Inventory # HP-11413
Quantity: 1 available
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condition: new. Hardcover. Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, house staff, fellows, practising clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. With contributions from experts across the United States and Canada, Prostate Cancer details the current management of prostate cancer and reviews new therapies in development for prostate cancer, with an emphasis on castration-resistant prostate cancer (CRPC). Coverage includes discussion of multiple new agents that have been shown to impact overall survival or improve skeletal-related events in metastatic CRPC as well as articles covering new data on screening and prevention, integration of surgery and radiation with newly emerging medical therapies, and coverage of the newest developments in immunotherapy. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows. Included in Prostate Cancer: Updates in Prostate Cancer Prevention Prostate Cancer Screening, 2011 Current Surgical Approaches to Primary Prostate Cancer Treatment Updates in Radiation Therapy for Prostate Cancer: Dose Matters An Update on Androgen-Deprivation Therapy for Advanced Prostate Cancer Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer New Understanding of Metabolic Complications of Androgen-Deprivation Therapy Current State of Docetaxel-Based Therapy in Castration-Resistant Prostate Cancer Second-Line Chemotherapy for Castration-Resistant Prostate Cancer Emerging Role of Immunotherapy in the Treatment of Prostate Cancer Novel Bone-Targeted Therapy in Metastatic Prostate Cancer Emerging Treatment Strategies for Metastatic Prostate Cancer: The Next Step Forward Prostate cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. This title provides a comprehensive review for practitioners on the status of prostate cancer treatment. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9781936287468
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 200 pages. 10.10x7.00x0.60 inches. In Stock. Seller Inventory # zk1936287463
Quantity: 1 available